Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients: results from a pan-European survey.
[en] [en] BACKGROUND: Bacterial infections frequently occur in haematological patients, especially during prolonged neutropenia after intensive chemotherapy, often leading to bloodstream infections and pneumonia.
OBJECTIVE: Routine antimicrobial prophylaxis (AMP) for high-risk haematology patients is still debated while prevalence of multi-drug resistant (MDR) Gram-negative bacteria (GNB) is rising globally. We aimed to assess the current practice of AMP in this population.
DESIGN: Cross-sectional observational survey study.
METHODS: Haematologists and infectious diseases physicians Europewide were invited to an online survey including questions on routine screening for GNB, incidence of MDR-GNB colonization, antimicrobial prophylaxis practices, rates of bloodstream infections (BSI), ICU admission and mortality differentiated by infections due to GNB versus MDR-GNB.
RESULTS: 120 haematology centres from 28 countries participated. Screening for MDR-GNB is performed in 86.7% of centres, mostly via rectal swabs (58.3%). In 39.2% of routine AMP is used, mostly with fluoroquinolones. Estimates of GNB-BSI yielded higher rates in patients not receiving anti-GNB prophylaxis than in those who do for E. coli (10% vs 7%) Klebsiella spp. (10% vs 5%), and Pseudomonas spp. (5% vs 4%). Rates for MDR-GNB infection were estimated lower in centres that administer AMP for MDR E. coli (5% vs 3%) Klebsiella spp. (5% vs 3%), and Pseudomonas spp. (2% vs 1%). In an exploratory analysis, Southern and Eastern European countries expected higher rates of MDR-GNB infections with lower ICU admission and mortality rates which may be subject to estimation bias.
CONCLUSION: Screening for MDR-GNB is frequently performed. AMP against GNB infections is still often implemented. Estimated BSI rates are rather low, while the rate of MDR-GNB infections rises. Tailored prophylaxis including antimicrobial stewardship becomes more important.
Disciplines :
Immunology & infectious disease
Author, co-author :
Stemler, Jannik; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany ; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine, and University Hospital Cologne, University of Cologne, Cologne, Germany ; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany
Gavriilaki, Eleni; 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Hlukhareva, Oksana; Clinical Center of Oncology, Hematology, Transplantology and Palliative Care of Cherkasy Oblast Council, Cherkasy, Ukraine
Khanna, Nina; Division of Infectious Diseases and Hospital Epidemiology, Departments of Biomedicine, University Hospital and University of Basel, Basel, Switzerland
Neofytos, Dionysios; Division of Infectious Diseases, Transplant Infectious Disease Service, University Hospital of Geneva, Geneva, Switzerland
Akova, Murat; Department of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey
Pagano, Livio; Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy
Cisneros, José-Miguel; Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocío University Hospital, Institute of Biomedicine of Seville (IBiS), CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain
Cornely, Oliver A; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany ; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine, and University Hospital Cologne, University of Cologne, Cologne, Germany ; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany ; University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), Cologne, Germany
Salmanton-García, Jon ; Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany ; Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine, and University Hospital Cologne, University of Cologne, Cologne, Germany ; German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Herderstraße 52, Cologne 50931, Germany
Other collaborator :
LAYIOS, Nathalie ; Centre Hospitalier Universitaire de Liège - CHU > > Service des soins intensifs
Language :
English
Title :
Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients: results from a pan-European survey.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Carvalho AS Lagana D Catford J, et al. Bloodstream infections in neutropenic patients with haematological malignancies. Infect Dis Health 2020; 25: 22–29.
Cornely OA Schirmacher P. Bacterial translocation in neutropenic sepsis. Lancet 2001; 358: 1842.
Lehrnbecher T Fisher BT Phillips B, et al. Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation. Clin Infect Dis 2019; 71: 226–236.
Taplitz RA Kennedy EB Bow EJ, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update. J Clin Oncol 2018; 36: 3043–3054.
Liss B Cornely OA. Burden and benefit of antibiotic prophylaxis in cancer chemotherapy. Lancet Infect Dis 2016; 16: 640.
Classen AY Henze L von Lilienfeld-Toal M, et al. Primary prophylaxis of bacterial infections and Pneumocystis Jirovecii Pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO). Ann Hematol 2021; 100: 1603–1620.
European Center for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases. European Center for Disease Prevention and Control. Stockholm, Sweden, http://atlas.ecdc.europa.eu/public/index.aspx (2022, accessed 2023).
Bert F Larroque B Paugam-Burtz C, et al. Pretransplant fecal carriage of extended-spectrum β-lactamase–producing enterobacteriaceae and infection after liver transplant, France. Emerg Infect Dis J 2012; 18: 908.
Reddy P Malczynski M Obias A, et al. Screening for extended-spectrum β-lactamase-producing enterobacteriaceae among high-risk patients and rates of subsequent Bacteremia. Clin Infect Dis 2007; 45: 846–852.
Tischendorf J de Avila RA Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control 2016; 44: 539–543.
Debby BD Ganor O Yasmin M, et al. Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis 2012; 31: 1811–1817.
Dubinsky-Pertzov B Temkin E Harbarth S, et al. Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and the risk of surgical site infection after colorectal surgery: a prospective cohort study. Clin Infect Dis 2019; 68: 1699–1704.
Papadimitriou-Olivgeris M Marangos M Fligou F, et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis 2013; 77: 169–173.
Frencken JF Wittekamp BHJ Plantinga NL, et al. Associations between enteral colonization with gram-negative bacteria and intensive care unit-acquired infections and colonization of the respiratory tract. Clin Infect Dis 2018; 66: 497–503.
Gorrie CL Mirčeta M Wick RR, et al. Gastrointestinal carriage is a major reservoir of klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis 2017; 65: 208–215.
Barbier F Pommier C Essaied W, et al. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure? J Antimicrob Chemother 2016; 71: 1088–1097.
Vehreschild MJGT Hamprecht A Peterson L, et al. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J Antimicrob Chemotherapy 2014; 69: 3387–3392.
Slavin MA Worth LJ Seymour JF, et al. Better sepsis management rather than fluoroquinolone prophylaxis for patients with cancer-related immunosuppression. J Clin Oncol 2019; 37: 1139–1140.
Bucaneve G Micozzi A Menichetti F, et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005; 353: 977–987.
Cullen M Steven N Billingham L, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005; 353: 988–998.
Taur Y Pamer EG. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis 2013; 26: 332–337.
Merdad R Alyami A Basalim A, et al. Bloodstream gram-negative bacterial infections in adult patients with leukemia: a retrospective review of medical records in a tertiary care hospital in Western Saudi Arabia. J Infection Public Health 2023; 16: 1525–1530.
Rodríguez-Baño J Gutiérrez-Gutiérrez B Machuca I, et al. Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and Carbapenemase-producing enterobacteriaceae. Clin Microbiol Rev 2018; 31(2): e00079-17.
Hendriksen RS Munk P Njage P, et al. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage. Nat Commun 2019; 10: 1124.
Leibovici L Paul M Cullen M, et al. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions. Cancer 2006; 107: 1743–1751.
Teillant A Gandra S Barter D, et al. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis 2015; 15: 1429–1437.
Mikulska M Averbuch D Tissot F, et al. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Infect 2018; 76: 20–37.
Willems RPJ van Dijk K Vehreschild M, et al. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis. Lancet Infect Dis 2023; 23: 719–731.
Biehl LM Higgins P Wille T, et al. Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards. Clin Microbiol Infect 2019; 25: 1013–1020.
Biehl LM Higgins PG Stemler J, et al. Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January-December 2016. Euro Surveill 2022; 27: 2001876.
Abad C Fearday A Safdar N. Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect 2010; 76: 97–102.
Morgan DJ Diekema DJ Sepkowitz K, et al. Adverse outcomes associated with Contact Precautions: a review of the literature. Am J Infect Control 2009; 37: 85–93.
Harris AD Pineles L Belton B, et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. Jama 2013; 310: 1571–1580.
Huskins WC Huckabee CM O’Grady NP, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med 2011; 364: 1407–1418.
Marra AR Edmond MB Schweizer ML, et al. Discontinuing contact precautions for multidrug-resistant organisms: a systematic literature review and meta-analysis. Am J Infect Control 2018; 46: 333–340.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
